Nanomedicine Market
Nanomedicine Market - Global Industry Assessment & Forecast
#
Pages:
149
2022
Jun - 2022
VMR-1632
Segments Covered
By
Modality Diagnostics, Treatment
-
By
Application Drug Delivery, Diagnostic Imaging, Vaccines, Regenerative Medicine, Implants, Others
-
By
Indication Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Neurology, Urology, Ophthalmology, Immunology, Others
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 188.05 Billion |
 Revenue 2030:
|
USD 366.53 Billion |
 Revenue CAGR
(2023 - 2030): |
8.70% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Research Methodology: Nanomedicine Market by Modality by Application by Indication by Region - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
Data Triangulation and Market Size Estimations
Vantage Market
Research | 06-Jun-2022
FAQ
Frequently Asked Question
What is the global demand for Nanomedicine in terms of revenue?
-
The global Nanomedicine valued at USD 188.05 Billion in 2022 and is expected to reach USD 366.53 Billion in 2030 growing at a CAGR of 8.70%.
Which are the prominent players in the market?
-
The prominent players in the market are Abbott Laboratories, DiaSorin S.P.A., General Electric Company, Invitae Corporation, Johnson & Johnson, Leadient BioSciences Inc., Mallinckrodt PLC, Merck & Co. Inc. Pfizer Inc., Teva Pharmaceuticals Ltd..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 8.70% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Nanomedicine include
- Rising level of government participation in R&D funding
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Nanomedicine in 2022.
